What is EchoNous?
Founded in 2016 and based in Redmond, WA, EchoNous is a software development company specializing in the creation of miniaturized ultrasound technology. The company is at the forefront of fusing this advanced hardware with artificial intelligence, aiming to revolutionize medical diagnostics and accessibility. EchoNous's focus on integrating AI with ultrasound positions it as a key innovator in the health-tech sector, addressing critical needs in medical imaging.
How much funding has EchoNous raised?
EchoNous has raised a total of $159M across 4 funding rounds:
Private Equity
$35M
Private Equity
$60M
Series D
$57M
Other Financing Round
$7M
Private Equity (2017): $35M with participation from KKR
Private Equity (2021): $60M led by Kennedy Lewis Investment Management
Series D (2022): $57M supported by Kennedy Lewis Investment Management
Other Financing Round (2023): $7M, investors not publicly disclosed
Key Investors in EchoNous
Kennedy Lewis Investment Management
Kennedy Lewis Investment Management is a multi-strategy private credit platform that specializes in non-sponsor lending and bespoke capital solutions for middle-market businesses. The firm focuses on providing creative capital solutions through a range of investment products, including opportunistic credit, core lending, homebuilder finance, and collateralized loan obligations.
KKR
KKR is a global investment firm investing across private markets in every asset class all over the world. KKR's mission is to fortify companies and communities and help secure the futures of the institutions and individuals counting on them. KKR have a deep commitment to our clients and portfolio companies and believe in shared success.
What's next for EchoNous?
With the recent major strategic investment, EchoNous is poised for accelerated growth and further development of its AI-powered miniaturized ultrasound solutions. This capital infusion is expected to fuel advancements in product refinement, market expansion, and the scaling of its operational capabilities. The company's strategic focus on integrating cutting-edge AI with medical imaging technology suggests a future aimed at enhancing diagnostic accuracy and patient care globally, potentially disrupting traditional medical device markets.
See full EchoNous company page
